Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.
Hakki, Morgan; Riddell, Stanley R; Storek, Jan; Carter, Rachel A; Stevens-Ayers, Terry; Sudour, Patrick; White, Kristen; Corey, Lawrence; Boeckh, Michael.
; 102(8): 3060-7, 2003 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-12843000
The role of ThPOK in control of CD4/CD8 lineage commitment.
Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans.
The biology of recent thymic emigrants.
CMV: Prevention, Diagnosis and Therapy.
Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation.
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.
Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
The human cytomegalovirus glycoprotein pUL11 acts via CD45 to induce T cell IL-10 secretion.
Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.